- Investing Ideas
- /
- U.S. Large Cap High Growth Potential
U.S. Large Cap High Growth Potential
Results
252
15 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
252 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ONON | US$58.47 | 13.6% | 107.3% | US$18.6b | US$58.68 | PE131.6x | E29.6% | n/a | Consumer Durables | ||
ALNY | US$250.98 | 8.1% | 57.7% | US$31.6b | US$301.21 | PS15.5x | E70.7% | n/a | Pharmaceuticals & Biotech | ||
ARES | US$176.03 | 5.1% | 61.6% | US$35.4b | US$174.38 | PE82.2x | E46.3% | 2.1% | Diversified Financials | ||
SRPT New | US$114.65 | 9.5% | 38.8% | US$10.9b | US$184.64 | PE89.9x | E42.9% | n/a | Pharmaceuticals & Biotech | ||
NVDA | US$136.02 | -2.9% | 182.0% | US$3.5t | US$170.44 | PE52.8x | E24.7% | 0.03% | Semiconductors | ||
NU | US$14.23 | 4.2% | 74.4% | US$66.9b | US$15.94 | PB8.9x | E29.0% | n/a | Banks | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | Pharmaceuticals & Biotech | ||
BX | US$193.12 | 5.5% | 80.9% | US$152.8b | US$169.65 | PE66.7x | E27.9% | 1.7% | Diversified Financials | ||
KSPI | US$106.19 | -3.6% | 10.6% | US$19.8b | US$139.13 | PE10.4x | E23.7% | 6.4% | Diversified Financials | ||
SMCI | US$38.41 | 78.3% | 32.3% | US$19.4b | US$40.32 | PE18.6x | E24.3% | n/a | Tech | ||
OWL | US$24.39 | 5.7% | 82.0% | US$14.0b | US$23.55 | PE129.7x | E59.2% | 3.0% | Diversified Financials | ||
DUOL | US$348.00 | 13.4% | 56.9% | US$15.5b | US$327.23 | PE176.4x | E41.6% | n/a | Consumer Services | ||
VRT | US$132.03 | 7.3% | 210.3% | US$52.6b | US$141.42 | PE85.2x | E31.2% | 0.1% | Capital Goods | ||
DASH | US$179.10 | 3.7% | 90.6% | US$73.6b | US$171.98 | PS7.3x | E56.0% | n/a | Consumer Services | ||
SN | US$102.71 | 3.3% | 120.3% | US$13.8b | US$121.69 | PE40.1x | E22.8% | 1.1% | Consumer Durables | ||
NTNX | US$72.80 | 6.2% | 78.3% | US$19.6b | US$75.53 | PS9.1x | E84.4% | n/a | Software | ||
EXE | US$98.87 | 2.5% | 21.2% | US$23.0b | US$103.90 | PE90x | E93.0% | 2.5% | Energy | ||
CTRA | US$26.99 | 3.3% | 2.7% | US$20.4b | US$32.46 | PE16.1x | E30.2% | 3.1% | Energy | ||
SPOT | US$481.38 | 5.9% | 163.0% | US$96.0b | US$466.97 | PE132.2x | E29.6% | n/a | Media | ||
XPEV | US$11.62 | -10.7% | -34.4% | US$11.3b | US$14.53 | PS2.1x | E63.7% | n/a | Automobiles | ||
ZS | US$210.42 | 3.7% | 9.6% | US$32.4b | US$218.01 | PS14.9x | E39.3% | n/a | Software | ||
TER | US$110.67 | 6.3% | 20.4% | US$17.6b | US$134.62 | PE35.1x | E21.7% | 0.4% | Semiconductors | ||
CVNA | US$260.80 | 6.6% | 743.2% | US$33.3b | US$245.81 | PE1971.5x | E44.9% | n/a | Retail | ||
ARM | US$139.68 | 8.6% | 129.0% | US$142.9b | US$145.42 | PE229x | E31.1% | n/a | Semiconductors |